NCT03117335 2017-04-17
Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
Phase 3 Completed
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
Genentech, Inc.
Merck KGaA, Darmstadt, Germany
Instituto Nacional de Cancer, Brazil